• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Effect of a mechanical vs a pharmacologic increase in aortic pressure on coronary blood flow and thrombolysis induced by IV administration of a thrombolytic agent.

作者信息

Prewitt R M, Gu S, Schick U, Ducas J

机构信息

Department of Medicine, University of Manitoba, Canada.

出版信息

Chest. 1997 Feb;111(2):449-53. doi: 10.1378/chest.111.2.449.

DOI:10.1378/chest.111.2.449
PMID:9041995
Abstract

This study was designed to compare the effect of a mechanical vs a pharmacologic increase in BP on coronary artery blood flow and thrombolysis induced by IV administration of recombinant tissue plasminogen activator. We employed a canine model of coronary thrombosis induced by injection of radioactive blood clot in the left anterior descending coronary artery. Subsequently, all dogs underwent phlebotomy to decrease systolic BP to 75 mm Hg and this decreased coronary blood flow by 50%. BP was increased to 130 mm Hg by norepinephrine (NE) infusion or by inflation of a Fogarty catheter placed in the descending aorta. Interventions with NE or with a Fogarty balloon catheter increased coronary artery blood flow to similar values and rates of coronary thrombolysis were similar. However, cardiac output was significantly higher with NE. These results indicate coronary clot lysis is dependent on perfusion pressure and coronary blood flow, not cardiac output.

摘要

相似文献

1
Effect of a mechanical vs a pharmacologic increase in aortic pressure on coronary blood flow and thrombolysis induced by IV administration of a thrombolytic agent.
Chest. 1997 Feb;111(2):449-53. doi: 10.1378/chest.111.2.449.
2
Marked systemic hypotension depresses coronary thrombolysis induced by intracoronary administration of recombinant tissue-type plasminogen activator.
J Am Coll Cardiol. 1992 Dec;20(7):1626-33. doi: 10.1016/0735-1097(92)90459-z.
3
An increase in low aortic pressure increases coronary artery flow and coronary thrombolysis induced by intravenous administration of recombinant tissue plasminogen activator.
J Crit Care. 1995 Mar;10(1):1-6. doi: 10.1016/0883-9441(95)90024-1.
4
Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent.
J Am Coll Cardiol. 1994 Mar 1;23(3):794-8. doi: 10.1016/0735-1097(94)90770-6.
5
Coronary thrombolysis with recombinant tissue plasminogen activator. Intracoronary vs intravenous administration.重组组织型纤溶酶原激活剂冠状动脉溶栓治疗。冠状动脉内给药与静脉内给药对比。
Chest. 1991 Jul;100(1):201-6. doi: 10.1378/chest.100.1.201.
6
Intravenous administration of recombinant tissue plasminogen activator. Optimizing the rate of coronary thrombolysis.重组组织型纤溶酶原激活剂的静脉给药。优化冠状动脉溶栓速率。
Chest. 1995 Apr;107(4):1146-51. doi: 10.1378/chest.107.4.1146.
7
Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.氧自由基清除剂在犬冠状动脉溶栓模型中作为组织型纤溶酶原激活剂辅助治疗的研究
Cardiovasc Res. 1993 Jun;27(6):925-34. doi: 10.1093/cvr/27.6.925.
8
Coronary thrombolysis. Comparative effects of intracoronary administration of recombinant tissue plasminogen activator and urokinase.冠状动脉溶栓。冠状动脉内注射重组组织型纤溶酶原激活剂与尿激酶的比较效果。
Chest. 1992 Jun;101(6):1684-90. doi: 10.1378/chest.101.6.1684.
9
Pathological basis of failure of concurrent glyceryl trinitrate therapy to improve efficacy of tissue type plasminogen activator in coronary thrombosis.硝酸甘油联合治疗未能提高组织型纤溶酶原激活剂对冠状动脉血栓形成疗效的病理基础。
Cardiovasc Res. 1991 Apr;25(4):283-9. doi: 10.1093/cvr/25.4.283.
10
Effect of rate of administration of recombinant tissue plasminogen activator on efficacy of coronary thrombolysis.重组组织型纤溶酶原激活剂给药速率对冠状动脉溶栓疗效的影响。
Angiology. 1994 Aug;45(8):687-94. doi: 10.1177/000331979404500803.

引用本文的文献

1
Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial.溶栓与反搏以改善合并低血压及疑似心源性休克或心力衰竭的心肌梗死患者的生存率:TACTICS试验结果
J Thromb Thrombolysis. 2005 Feb;19(1):33-9. doi: 10.1007/s11239-005-0938-0.